Approved Study Database
Ref. No. | Scientific Title | Principal investigator |
---|---|---|
2013.256 | Phase 2 study on safety and efficacy of irreversible electroporation for inoperable hepatic and pancreatic malignancy | Prof. YU Simon |
2006.310 | Phase 2 Study of SU011248 in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma | Prof. Chan T.C. Anthony |
2024.379 | Phase 2 Study of Futibatinib 20 mg and 16 mg in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements | Prof. CHAN Stephen Lam |
2010.253 | Phase 2 Study of Axitinib in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma | Prof. CHAN Anthony |
2021.280 | Phase 1b/2 Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia |
Prof. LI Chi Kong 李志光 |
2018.123 | Phase 1b/2 Safety, Pharmacokinetic, and Efficacy Study of G1T38 in Combination with Osimertinib in Patients with EGFR Mutation-Positive Metastatic Non-Small Cell Lung Cancer (NSCLC) |
Prof. MOK Tony Shu Kam 莫樹錦 |
2017.661 | PHASE 1/2 STUDY OF TAS-120 IN PATIENTS WITH ADVANCED SOLID TUMORS HARBORING FGF/FGFR ABERRATIONS |
Dr. CHAN Stephen Lam 陳林醫生 |
2014.528 | Phase 1/2 Study of PF-06463922 (An ALK/ROS1 Tyrosine Kinase Inhibitor) in Patients with Advanced Non-Small Cell Lung Cancer Harboring Specific Molecular Alterations | Prof. MOK Tony Shu Kam |
2019.342 | Phase 1/2 Dose-Escalation and Expansion Study of FLX475 Alone and in Combination with Pembrolizumab in Advanced Cancer |
Prof. MA Brigette Buig Yue 馬碧如教授 |
2007.312 | Phase 1 Study of OPB-31121 in Patients with Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple Myeloma | Dr. Lei I.K. Kenny |
2010.596 | Phase 1 Randomised study to assess immunogenicity, reactogenecity, safety and tolerability of two pneumococcal conjugate vaccines administered intraderamlly and intramuscularly to adults aged 20 to 50 years | Prof NELSON Edmund A.S. |
2024.106 | Phase 1 randomised controlled clinical trial testing the safety and efficacy of CPP-anti-VEGF for the treatment of neovascular age-related macular degeneration | Dr. BRELEN Mårten Erik |
2012.337 | Phase 1 Clinical Trial to Establish the Safety and Feasibility of Brain Transplants of Umbilical Cord Blood Mononuclear Cells in Chronic Ischemic Stroke | Prof. POON Wai Sang |
2018.582 | Pharmacological Treatment of Mitochondrial Dysfunction in Diabetic Kidney Disease |
Prof. SZETO Cheuk Chun 司徒卓俊 |
2008.180 | Pharmacokinetics, Pharmacogenomics and Toxicity of Efavirenz in Chinese Patients with HIV Infection | Prof. LEE Shui Shan |
2016.263 | Pharmacokinetics study of Trazodone Hydrochloride Prolonged-release tablets in Chinese Healthy Volunteers | Dr. LUK Andrea On Yan |
2006.462 | Pharmacokinetics of Single and Repeated Oral Administration of S 33138 20 mg Daily in Chinese Healthy Male and Female Volunteers | Prof. Tomlinson Brian |
2005.370 | Pharmacokinetics of Single and Repeated Oral Administration of S 18886 30mg Daily in Chinese Healthy Male Volunteers | Prof. Brian Tomlinson |
2011.158 | Pharmacokinetics of Oseltamivir in Adult Chinese Hospitalized for Severe Influenza Infection and its Impact on Viral Clearance | Dr Lee Nelson |
2020.284 | Pharmacokinetics and safety profile of Apixaban in patients with peritoneal dialysis |
Dr. FUNG Winston Wing Shing 馮永丞 |
2023.034 | Pharmacokinetic study of vancomycin and meropenem and a pilot paediatric antibiotic stewardship program |
Prof. NG Wai Yin 吳煒燕 |
2013.407 | Pharmacokinetic study of once-daily formulation of Tacrolimus (Advagraf_) in Chinese kidney transplant patients | Dr Ma King Wing, Terry |
2007.452 | Pharmacokinetic Study of Doxorubicin Delivered Through Transarterial Administered of Four Different Doxorubicin-Loaded Formulations for Hepatocellular Carcinoma | Dr Yu Simon |
2011.390 | Pharmacokinetic interaction between rosuvastatin and telmisartan | Prof. TOMLINSON Brian |
2019.688 | Pharmacokinetic and pharmacodynamic study of a novel sublingual aspirin tablet compared to conventional oral aspirin in healthy subjects | Prof. CHOW Elaine |
2004.291 | Pharmacokinetic and Pharmacodynamic Effects of a Special Buffered Propranolol Formulation for Sublingual Administration | Prof. Chow S.S. Moses |
2010.322 | Pharmacogenomics of nicotinic acid with laropiprant in Hong Kong Chinese patients with dyslipidemia | Prof Tomlinson Brian |
2010.163 | Pharmacogenomics of nicotinic acid with laropiprant in Hong Kong Chinese patients with dyslipidemia | Prof Tomlinson Brian |
2011.472 | Pharmacogenomics of Niacin in Patients with Erectile Dysfunction and Dyslipidaemia - a Follow-on Study | Prof Tomlinson Brian |
2013.052 | Pharmacogenomics of anti-hypertensive treatment in Chinese, from unpredictable response to personalized medicine | Prof Tomlinson Brian |
2022.524 | Pharmacogenomics in childhood leukemia: a retrospective study | Dr. LEUNG Kam Tong |
2004.060 | Pharmacogenetics of Warfarin Elimination and its Clinical Implications in Chinese Patients | YOU Hoi Sze Joyce |
2006.147 | Pharmacogenetics of HMG Co-A Reductase Inhibitors in Chinese Patients with Hyperlipidaemia: A Combined Pharmacodynamic Pharmacokinetic Approach | Prof. TOMLINSON Brian |
2006.315 | Pharmacogenetics of Fluoxetine in Chinese Patients (Protocol No. RES-06-01) | CHOW Sing Sum Moses |
2004.401 | Pharmacogenetics of Citalopram and Venlafaxine in Chinese Patients (Proposal of Research Project 2004/2005 - PHA 3611 PHARMACY CLERKSHIP/PROJECT) | CHOW SS Moses |
2013.418 | Pharmacogenetics of antiretroviral therapy for HIV infection in Hong Kong | Prof. CHAN Denise Pui Chung |
2009.639 | Pharmacogenetics of Angiotensin Converting Enzyme Inhibitor (ACEI)-Related Cough | Prof. Brian Tomlinson |
2010.525 | Pharmacogenetic Analysis of the effects of Nicotinic acid and Fenofibrate on rEsidual carDiOvascular risks, liveR fat and carotid Atherosclerosis in Chinese patients treated with statins, a prospective randomized clinical trial | Prof Tomlinson Brian |
2016.623 | Pharmacoepidemiology and pharmacoeconomics of oral anticoagulation therapy in Hong Kong | Dr. YAN Bryan Ping Yen |
2014.679 | Pharmacodynamics and Pharmacokinetics of Oseltamivir in Critically Ill Patients with Severe Influenza | Dr. WONG Wai Tat |
2012.339 | Pharmacist Intervention and Screening of Potentially Inappropriate Medications on Hospitalized Geriatric Patients in Hong Kong | Mr Mak Wun Cheung |
2008.510 | Phaco-Trabeculectomy with Adjunctive Intra-Vitreal Injection of Bevacizumab (Avastin). A Preliminary Study. | Professor Lam Dennis Shun Chiu |
2018.110 | Perturbation of retinoic acid homeostasis in fetal programming of type 2 diabetes in offspring of diabetic pregnancy |
Prof. SHUM Alisa Sau Wun 沈秀媛 |
2014.670 | Perturb and Observe: Examining the Role of the Frontal Cortex in Change Detection Using Stimultaneous Transcranial Magnetic Stimulation and Event-related Optical Signals | Dr. TSE Chun Yu |
2023.693 | Perspectives on illness perception and self-management behaviours from patients with non-alcoholic fatty liver disease and healthcare professionals: An exploratory qualitative study | Ms. MA Angel Cho Kan |
2022.368 | Perspectives of End-of-Life Patients and Their Family Members on Advance Care Planning in Hong Kong | Dr Lee Jenny Shun Wah |
2018.338 | Personalized Risk-based Care and Education for Early Survivors of Childhood Cancer in Hong Kong (Phase 2) |
Dr. CHEUNG Yin Ting 張彥婷 |
2024.138 | Personalized Rehabilitation Pathways to Maximal Motor Functional Return through an AI Recovery Prediction System for Diverse Stroke Survivors |
Prof. CHEUNG Vincent Chi Kwan 張智鈞 |
2019.029 | Personalized Procedural Simulation for Transcatheter Aortic Valve Implantation using 3D Printed Models: A Randomized Clinical Trial |
Dr. LEE Pui Wai 李沛威 |
2021.282 | Personalized intellectually stimulating intervention for cognitive maintenance and healthy ageing | Dr. LEE Allen Ting Chun |
Page 77 of 254.